title: Reversal of the measles virus-mediated increase of phosphorylating activity in persistently infected mouse neuroblastoma cells by anti-measles virus antibodies.
abstract: To investigate the effect of persistent measles virus infection on signal transduction in cells of neuronal origin, the mouse neuroblastoma cell line NS20Y/MS, which is persistently infected with measles virus, was used. The results demonstrate an approximate 50% increase in total phosphorylation and a similar increase in protein kinase C (PKC) activity. Western blot analysis with anti-total PKC or anti-PKC-alpha antibodies revealed a significant increase in the level of an 80K immunoreactive PKC in NS20Y/MS cells. Following incubation of NS20Y/MS cells with polyclonal anti-measles virus antibodies, which down-regulate the level of measles virus proteins, total and PKC-mediated phosphorylation returned to the basal level of uninfected cells. This effect was reversible and removal of the antibodies resulted in restoration of the high level of total and PKC-mediated phosphorylation. The release of infectious measles virus was strongly inhibited by incubation of NS20Y/MS cells with the PKC inhibitor, 1-(5-isoquinolinylsulphonyl)-2-methylpiperazine (H-7). These results demonstrate that measles virus induces elevation in cellular phosphorylation which is essential for measles virus production.
authors.affiliation: Ben Gurion University of the Negev, Department of Microbiology and Immunology, Beer Sheva, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Segev
authors.forename: B
authors.initials: B
authors.lastname: Rager-Zisman
authors.forename: N
authors.initials: N
authors.lastname: Isakov
authors.forename: S
authors.initials: S
authors.lastname: Schneider-Schaulies
authors.forename: V
authors.initials: V
authors.lastname: ter Meulen
authors.forename: S
authors.initials: S
authors.lastname: Udem
authors.forename: S
authors.initials: S
authors.lastname: Segal
authors.forename: M
authors.initials: M
authors.lastname: Wolfson
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000914:Antibodies, Viral / Q000276:immunology*; D003600:Cytosol / Q000737:chemistry; D015536:Down-Regulation / Q000187:drug effects; D007106:Immune Sera; D007546:Isoquinolines / Q000494:pharmacology; D008459:Measles virus / Q000276:immunology / Q000502:physiology*; D008565:Membrane Proteins / Q000032:analysis; D051379:Mice; D009500:Neutralization Tests; D010766:Phosphorylation / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology; D011493:Protein Kinase C / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D007106:Immune Sera; D007546:Isoquinolines; D008565:Membrane Proteins; D010879:Piperazines; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D011493:Protein Kinase C